Trial Profile
Tolerability of imiquimod versus photodynamic therapy with methyl aminolevulinate in patients with actinic keratosis of the face and scalp.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jan 2012
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary) ; Methyl aminolevulinate (Primary)
- Indications Actinic keratosis; Skin cancer
- Focus Adverse reactions; Therapeutic Use
- 06 Jan 2012 Results published in the Journal of the American Academy of Dermatology.
- 09 Mar 2011 New trial record